/Investor DB

AlbionVC — 2020 Investments

5 investments dated 2020 · listed companies and verified rows first · show all

AstronauTX Ltdastronautx.bioinMar 2020 · $1M

AstronauTx is a biotechnology company focused on drug discovery and development for neurodegenerative and neuroinflammatory diseases, working across small molecules and biologics.

BiotechDeep TechHealthtechLongevityMedical Devices

Jane Rhodes(Chief Executive Officer)inMagnus Ivarsson(Chief Scientific Officer)inHannah Pearce(Chief Operating Officer)inMichelle L. Mellion(Chief Medical Officer)in

Co-investorsBrandon CapitalBrandon Capital PartnersDementia Discovery FundMPM BioImpactNovartis Venture FundSV Health Investors+1 more

Concirrusconcirrus.aiinFeb 2020 · $20M

Concirrus provides AI-driven submission automation that ingests, cleans, and structures complex risk data across specialty insurance lines, returning underwriter-ready data into rating and core systems.

AI & Machine LearningInsurTechSaaS

Andrew Yeoman(Founder & CEO)inVinod Singh(Co-Founder & President)inRuth Polyblank(Product and Strategy Director)inMatthew Twist(Commercial Director)inAnkur Jain(VP Engineering)inMalgorzata Jermakowicz(Head of HR and Administration)in

Co-investorsAngel AcademeCommerzVenturesEos Venture Partners LimitedIQ Capital

Credit Kudoscreditkudos.comSeries A · Apr 2020 · $6Macquired by Apple

Credit Kudos was a UK credit reference agency that used Open Banking data to help lenders judge whether applicants could afford to repay.

FintechLondon, GB

Freddy Kelly(CEO)inMatt Schofield(Founding CTO)in

Co-investorsAscensionEntrepreneur FirstNFT VenturesPortfolio VenturesAngel InvestAscension Ventures+7 more

uMedumed.ioDec 2020

uMed provides data and insights infrastructure to accelerate the development and delivery of new medicines by addressing evidence gaps across the therapy lifecycle.

AI & Machine LearningBiotechData & InfrastructureDigital HealthHealthtechMedical Devices

Co-investors11.2 CapitalDelin VenturesPlayfair Capital

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Umedeor

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.